Shenzhen Zeyi and a number of Nobel Prize winners and academicians jointly launched the "Tiannian Ark Program".
On September 16, the 2023 Cell and Gene Industry Conference of Shenzhen Dapeng New Area with the theme of "Cells Promote Health and Industry Promote Development" was held in the exhibition hall of Shenzhen International Biovalley Light Core Start-up Area.
The inauguration ceremony of Shenzhen Zeyi Cell Therapy Group (hereinafter referred to as "Shenzhen Zeyi") was held on site. At the same time, Shenzhen Zeyi jointly launched the "Tiannian Ark Project" together with a number of Nobel laureates, academicians, top scientists and medical experts at home and abroad.
The new star of the whole industry chain platform of cell therapy landed in Dapeng New District
The conference was guided by Shenzhen Science and Technology Innovation Commission and Shenzhen Dapeng New Area Management Committee, hosted by Shenzhen Zeyi Cell Therapy Group, and co-organized by Shanghai Wu Mengchao Medical Science and Technology Foundation.
The conference specially invited leaders of relevant government departments, authoritative academicians, well-known industry experts and scholars and industry leaders to attend, Nobel Prize winners in chemistry Aliye Vashel, Michael Levitt at the conference site to give cancer prevention and treatment related theme reports, the conference attracted industry elites from all over the country to participate on the spot.
At the conference, the organizer carried out the inauguration ceremony of Shenzhen Zeyi Cell Therapy Group and the release ceremony of the Tiannian Ark Plan, marking that Shenzhen International Biovalley located in Dapeng New Area has added another beautiful new "business card" of cells and genes, a future industry, and another benchmark enterprise in the international biovalley cell and gene industry.
It is understood that Shanghai Cell Therapy Group Co., Ltd. is a high-tech company established on the basis of the municipal engineering technology research center approved by the Shanghai Municipal Science and Technology Commission, with "innovative cell therapy" as the engine, integrating "cell drug research and development, cell cryopreservation and preparation and clinical transformation of precision cell therapy", is the only cell therapy institution with a complete industrial chain closed loop in China, has a leading team and technical advantages in the field of cell therapy industry, and has become a leading enterprise in the industry in China.
Under the joint promotion of the Dapeng New Area Science and Technology Innovation and Economic Service Bureau, the Personnel Bureau, the Education and Health Bureau, Shenzhen Dapeng New Area Industrial Investment Group Co., Ltd. and other departments, Shenzhen Zeyi Cell Therapy Group, the South China headquarters project of Shanghai Cell Therapy Group, settled in Dapeng New District, Shenzhen in December 2022, and after one year of preparatory construction, Shenzhen Zeyi Cell Therapy Group project was officially completed and put into operation.
Four major sectors will be built, including the human body 4S store health management center
According to reports, Shenzhen Zeyi Cell Therapy Group will invest in the construction of four major sectors, including the Cell Therapy Research Institute, the Nanobody Research Center and Laboratory Institute, the largest cell cryopreservation bank in the Guangdong-Hong Kong-Macao Greater Bay Area, and the health management center of the human 4S store, in the Baguang International Biovalley of Dapeng New Area, Shenzhen, and gradually build a leading platform for the whole industry chain of "production, learning, research and medicine" in the field of cell therapy in the Guangdong-Hong Kong-Macao Greater Bay Area, and is committed to becoming a new benchmark for cell therapy in the Guangdong-Hong Kong-Macao Greater Bay Area.
It is worth mentioning that Shenzhen Zeyi Cell Therapy Group and Sun Yat-sen University, South China University of Technology, Jinan University, Southern Medical University, Guangzhou University of Chinese Medicine and other units of the superior team in the field of cell therapy and well-known experts cooperate closely, will build a "production, learning, research and medicine" cooperation platform in the field of cell therapy, around the basic, application and clinical transformation problems in the field of cell therapy, carry out multi-angle and in-depth systematic research, through strong alliance, complementary advantages of integrated research. Explore key common scientific issues in the field of cell therapy, develop new technologies and products of cell therapy, cultivate professionals in the field of cell therapy, promote the improvement of the scientific and standardized level of the cell therapy industry, and promote the healthy and sustainable development of the cell therapy industry.
Bai Zongke, chairman of Shenzhen Zeyi Cell Therapy Group, said in an interview, "The choice to settle in Dapeng is that Shenzhen has a good policy environment, the government has the spirit of serving enterprises, high efficiency, and many innovative industries have also issued corresponding regulatory guidance; Second, Dapeng is a city of mountains and seas, which is conducive to scientists' peace of mind in scientific research and away from the hustle and bustle; Third, the talent policy is good, which can properly solve the worries of scientists, such as the problem of children going to school. At the same time, Bai Zongke said on the spot: "In the future, the group will gather strength, high standards and refined services to build an international first-class cancer prevention and treatment center." ”
With precision cell therapy technology
Trying to keep people healthy and live long into their lives
The cell therapy specialized in Shenzhen Zeyi is an emerging medical method. Cell therapy breaks through the limitations of traditional surgery and drug treatment, and provides new treatment ideas and approaches for diseases such as cancer. In recent years, with the explosion of a large number of excellent clinical data, the efficacy of cell therapy has gained global consensus.
According to statistics, in 2019, the number of new cancer cases in people under 50 years old was 1.82 million, an increase of 79% over 1990, and by 2030, the number of new cancer cases and related deaths in people under 50 years old in the world will continue to rise.
In order to achieve the mission of conquering cancer, Shenzhen Zeyi, together with a number of Nobel laureates, academicians, top scientists and medical experts at home and abroad, jointly launched the "Ark Project", which aims to enable people to live healthily to the next year through precision cell therapy technology within 20 years.
Cui Baoshan, co-chairman of the Cancer Prevention and Development Special Fund of the China Health Promotion Foundation, introduced that the "Tiannian Ark Program" originated from the layout of cell therapy by Academician Wu Mengchao in 2000, and it is also the inheritance of Academician Wu Mengchao's last wish. The main purpose is to use the latest technology, gene therapy, cell therapy, so that more people can live a long and healthy life.
Previously, under the leadership of Academician Wu Mengchao, China has made rapid progress in the field of cell therapy. In just 23 years, mainland cell technology has achieved curve overtaking, and related scientific research projects are comparable to those in the United States, far surpassing Japan and Europe.
After the opening ceremony, the Cell and Gene Industry Conference and Cancer Prevention and Treatment Lectures were held one after another, and a number of authoritative academicians, well-known industry experts and scholars and industry leaders discussed the application development, opportunities and challenges of cell therapy in cancer prevention and treatment in depth.
focus
In the eyes of Nobel laureates, what is the attraction of Shenzhen?
What is the appeal of Shenzhen in the eyes of Nobel laureates? Journalists got different answers.
Michael Levitt, winner of the 2013 Nobel Prize in Chemistry, said, "I have been to many places in China, I have been to Shenzhen about 5 times, and I think Shenzhen is very special and the location is also very superior. In China, Shenzhen is considered a city of innovation, and new ideas and initiatives will be tried by Shenzhen and then popularized. The application of Shenzhen's innovative ideas in the biomedical industry is also very conducive to the development of the industry. ”
At the same time, he added, "I think that no matter what country you invest in a field, as long as you have good people, things can happen, whereas in science, you never know what will happen." I think Chinese scientists have shown that they can develop new things. ”
Professor Aliye Washel, Nobel Prize winner in chemistry and founder of the Warshel Institute of Computational Biology at Chinese University of Hong Kong, Shenzhen, believes that "Shenzhen is a young city with a concentration of young people, full of infinite possibilities, and has a good scientific and technological foundation in the field of biomedicine and other related fields, and has developed rapidly. ”
In fact, he came to Shenzhen in 2014 to see and learn more about CUHK-Shenzhen as a young university full of potential. "Here, I also feel the rapid development of Shenzhen, which I think is a good place."
Area observation
From January to August, Dapeng introduced 85 enterprises in the fields of registered biology
In recent years, Dapeng New Area has actively seized the major historical opportunity of the construction of the Guangdong-Hong Kong-Macao Greater Bay Area and the Shenzhen Pilot Demonstration Zone, centered on the goal of striving to build a practical innovation benchmark of "green water and green mountains are golden mountains and silver mountains", led economic transformation and upgrading with Shenzhen's "20+8" industrial development, accelerated the construction of "4+3+N" modern industrial clusters, accelerated the construction of two key areas of Baguang and Longqiwan, and actively laid out industrial clusters such as biomedicine, health, synthetic biology, cells and genes. Actively promote the construction of the Pingshan-Dapeng Guangdong-Hong Kong-Macao Greater Bay Area Life and Health Innovation Demonstration Zone and the Precision Medicine Pioneer Zone with high standards.
This year, Dapeng New Area has made efforts to tackle projects, education industries and excellent environment, promote the acceleration of high-quality industries and high-end projects in the jurisdiction, and introduce 85 registered biological, marine, food, new energy, advanced manufacturing and other fields from January to August, at the same time, reserve more than 70 investment projects, investment of more than 60 billion yuan, is expected to form an output value (revenue) of more than 70 billion yuan, biomedicine, cells and genes, food health, marine science and technology and other strategic emerging industries agglomeration effect is becoming more prominent. Form a more competitive modern industrial ecology.
Written by: Nandu reporter Chen Xinghua Correspondent Ye Siqin He Weiwei Comprehensive Shenzhen Satellite TV Deep View News